Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).

<p>Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).</p>

Saved in:
Bibliographic Details
Main Author: Maria Paula Gomes Mourão (7329683) (author)
Other Authors: Gisely Cardoso de Melo (9340228) (author), Joabi Nascimento (5954135) (author), Victor Irungu Mwangi (12466086) (author), Livia Sacchetto (18156103) (author), Luiz Gustavo Gardinassi (3340488) (author), Rebeca Linhares Abreu Netto (11769638) (author), Jady Mota (22367363) (author), Sergio Damasceno Pinto (17030163) (author), Mayara Tavares (22367366) (author), Liz Moreira Cordeiro (22367369) (author), Barbara Seffair de Castro (22404310) (author), de Abreu Brasil (22404313) (author), Dyandra dos Santos Porto (22367372) (author), Bianca Daniele Silva de Oliveira (22367375) (author), Ana Carolina Shuan Laco (22367378) (author), Lorenna Pereira de Souza (22367381) (author), Karolaine Oliveira Bentes (22367384) (author), Marcia Castilho (22367387) (author), Carlos Eduardo Morais (22367390) (author), Heline Silva Lira (22367393) (author), Luís Felipe Alho (22367396) (author), Flor Ernestina Martínez Espinosa (22367399) (author), Vanderson Sampaio (4722609) (author), Felipe Murta (6917279) (author), Marco Aurélio Sartim (6300824) (author), Maurício Lacerda Nogueira (9460785) (author), Marcus Lacerda (742724) (author), Wuelton Monteiro (752733) (author)
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1852016042105110528
author Maria Paula Gomes Mourão (7329683)
author2 Gisely Cardoso de Melo (9340228)
Joabi Nascimento (5954135)
Victor Irungu Mwangi (12466086)
Livia Sacchetto (18156103)
Luiz Gustavo Gardinassi (3340488)
Rebeca Linhares Abreu Netto (11769638)
Jady Mota (22367363)
Sergio Damasceno Pinto (17030163)
Mayara Tavares (22367366)
Liz Moreira Cordeiro (22367369)
Barbara Seffair de Castro (22404310)
de Abreu Brasil (22404313)
Dyandra dos Santos Porto (22367372)
Bianca Daniele Silva de Oliveira (22367375)
Ana Carolina Shuan Laco (22367378)
Lorenna Pereira de Souza (22367381)
Karolaine Oliveira Bentes (22367384)
Marcia Castilho (22367387)
Carlos Eduardo Morais (22367390)
Heline Silva Lira (22367393)
Luís Felipe Alho (22367396)
Flor Ernestina Martínez Espinosa (22367399)
Vanderson Sampaio (4722609)
Felipe Murta (6917279)
Marco Aurélio Sartim (6300824)
Maurício Lacerda Nogueira (9460785)
Marcus Lacerda (742724)
Wuelton Monteiro (752733)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Maria Paula Gomes Mourão (7329683)
Gisely Cardoso de Melo (9340228)
Joabi Nascimento (5954135)
Victor Irungu Mwangi (12466086)
Livia Sacchetto (18156103)
Luiz Gustavo Gardinassi (3340488)
Rebeca Linhares Abreu Netto (11769638)
Jady Mota (22367363)
Sergio Damasceno Pinto (17030163)
Mayara Tavares (22367366)
Liz Moreira Cordeiro (22367369)
Barbara Seffair de Castro (22404310)
de Abreu Brasil (22404313)
Dyandra dos Santos Porto (22367372)
Bianca Daniele Silva de Oliveira (22367375)
Ana Carolina Shuan Laco (22367378)
Lorenna Pereira de Souza (22367381)
Karolaine Oliveira Bentes (22367384)
Marcia Castilho (22367387)
Carlos Eduardo Morais (22367390)
Heline Silva Lira (22367393)
Luís Felipe Alho (22367396)
Flor Ernestina Martínez Espinosa (22367399)
Vanderson Sampaio (4722609)
Felipe Murta (6917279)
Marco Aurélio Sartim (6300824)
Maurício Lacerda Nogueira (9460785)
Marcus Lacerda (742724)
Wuelton Monteiro (752733)
author_role author
dc.creator.none.fl_str_mv Maria Paula Gomes Mourão (7329683)
Gisely Cardoso de Melo (9340228)
Joabi Nascimento (5954135)
Victor Irungu Mwangi (12466086)
Livia Sacchetto (18156103)
Luiz Gustavo Gardinassi (3340488)
Rebeca Linhares Abreu Netto (11769638)
Jady Mota (22367363)
Sergio Damasceno Pinto (17030163)
Mayara Tavares (22367366)
Liz Moreira Cordeiro (22367369)
Barbara Seffair de Castro (22404310)
de Abreu Brasil (22404313)
Dyandra dos Santos Porto (22367372)
Bianca Daniele Silva de Oliveira (22367375)
Ana Carolina Shuan Laco (22367378)
Lorenna Pereira de Souza (22367381)
Karolaine Oliveira Bentes (22367384)
Marcia Castilho (22367387)
Carlos Eduardo Morais (22367390)
Heline Silva Lira (22367393)
Luís Felipe Alho (22367396)
Flor Ernestina Martínez Espinosa (22367399)
Vanderson Sampaio (4722609)
Felipe Murta (6917279)
Marco Aurélio Sartim (6300824)
Maurício Lacerda Nogueira (9460785)
Marcus Lacerda (742724)
Wuelton Monteiro (752733)
dc.date.none.fl_str_mv 2025-10-03T18:00:22Z
dc.identifier.none.fl_str_mv 10.1371/journal.pntd.0013604.t004
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Hematological_and_biochemical_profile_of_OROV-positive_patients_by_different_diagnostic_methods_PCR_versus_PRNT_/30275750
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Medicine
Microbiology
Neuroscience
Biotechnology
Immunology
Cancer
Mental Health
Infectious Diseases
Virology
Computational Biology
unprecedented rapid spread
syndromic diagnostic approach
significantly higher frequencies
potential neurological complications
oropouche virus disease
ongoing localized transmission
neutralizing antibody titer
mitigate future outbreaks
like dengue virus
expanding geographic range
eotaxin ), cxcl10
elevated alanine aminotransferase
continued genomic surveillance
2024 oropouche virus
orov symptoms overlap
expanded clinical studies
pcr positive samples
urine samples
serum samples
samples collected
xlink ">
using serum
time pcr
term consequences
study aimed
severe headache
rash compared
phase ccl11
orov infection
orov diagnosis
improving diagnosis
immunological profiles
high incidence
fold increase
endemic regions
denv underscores
denv infection
denv cases
day 28
cytokine profiles
considered orov
compare clinical
clinical manifestations
better understand
assess long
also observed
5 increased
45 %.
28 days
2024 outbreak
dc.title.none.fl_str_mv Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description <p>Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).</p>
eu_rights_str_mv openAccess
id Manara_ca4d0bdf2aa0b0165fcdfac876deed82
identifier_str_mv 10.1371/journal.pntd.0013604.t004
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30275750
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).Maria Paula Gomes Mourão (7329683)Gisely Cardoso de Melo (9340228)Joabi Nascimento (5954135)Victor Irungu Mwangi (12466086)Livia Sacchetto (18156103)Luiz Gustavo Gardinassi (3340488)Rebeca Linhares Abreu Netto (11769638)Jady Mota (22367363)Sergio Damasceno Pinto (17030163)Mayara Tavares (22367366)Liz Moreira Cordeiro (22367369)Barbara Seffair de Castro (22404310)de Abreu Brasil (22404313)Dyandra dos Santos Porto (22367372)Bianca Daniele Silva de Oliveira (22367375)Ana Carolina Shuan Laco (22367378)Lorenna Pereira de Souza (22367381)Karolaine Oliveira Bentes (22367384)Marcia Castilho (22367387)Carlos Eduardo Morais (22367390)Heline Silva Lira (22367393)Luís Felipe Alho (22367396)Flor Ernestina Martínez Espinosa (22367399)Vanderson Sampaio (4722609)Felipe Murta (6917279)Marco Aurélio Sartim (6300824)Maurício Lacerda Nogueira (9460785)Marcus Lacerda (742724)Wuelton Monteiro (752733)MedicineMicrobiologyNeuroscienceBiotechnologyImmunologyCancerMental HealthInfectious DiseasesVirologyComputational Biologyunprecedented rapid spreadsyndromic diagnostic approachsignificantly higher frequenciespotential neurological complicationsoropouche virus diseaseongoing localized transmissionneutralizing antibody titermitigate future outbreakslike dengue virusexpanding geographic rangeeotaxin ), cxcl10elevated alanine aminotransferasecontinued genomic surveillance2024 oropouche virusorov symptoms overlapexpanded clinical studiespcr positive samplesurine samplesserum samplessamples collectedxlink ">using serumtime pcrterm consequencesstudy aimedsevere headacherash comparedphase ccl11orov infectionorov diagnosisimproving diagnosisimmunological profileshigh incidencefold increaseendemic regionsdenv underscoresdenv infectiondenv casesday 28cytokine profilesconsidered orovcompare clinicalclinical manifestationsbetter understandassess longalso observed5 increased45 %.28 days2024 outbreak<p>Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).</p>2025-10-03T18:00:22ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pntd.0013604.t004https://figshare.com/articles/dataset/Hematological_and_biochemical_profile_of_OROV-positive_patients_by_different_diagnostic_methods_PCR_versus_PRNT_/30275750CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/302757502025-10-03T18:00:22Z
spellingShingle Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).
Maria Paula Gomes Mourão (7329683)
Medicine
Microbiology
Neuroscience
Biotechnology
Immunology
Cancer
Mental Health
Infectious Diseases
Virology
Computational Biology
unprecedented rapid spread
syndromic diagnostic approach
significantly higher frequencies
potential neurological complications
oropouche virus disease
ongoing localized transmission
neutralizing antibody titer
mitigate future outbreaks
like dengue virus
expanding geographic range
eotaxin ), cxcl10
elevated alanine aminotransferase
continued genomic surveillance
2024 oropouche virus
orov symptoms overlap
expanded clinical studies
pcr positive samples
urine samples
serum samples
samples collected
xlink ">
using serum
time pcr
term consequences
study aimed
severe headache
rash compared
phase ccl11
orov infection
orov diagnosis
improving diagnosis
immunological profiles
high incidence
fold increase
endemic regions
denv underscores
denv infection
denv cases
day 28
cytokine profiles
considered orov
compare clinical
clinical manifestations
better understand
assess long
also observed
5 increased
45 %.
28 days
2024 outbreak
status_str publishedVersion
title Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).
title_full Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).
title_fullStr Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).
title_full_unstemmed Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).
title_short Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).
title_sort Hematological and biochemical profile of OROV-positive patients by different diagnostic methods (PCR versus PRNT).
topic Medicine
Microbiology
Neuroscience
Biotechnology
Immunology
Cancer
Mental Health
Infectious Diseases
Virology
Computational Biology
unprecedented rapid spread
syndromic diagnostic approach
significantly higher frequencies
potential neurological complications
oropouche virus disease
ongoing localized transmission
neutralizing antibody titer
mitigate future outbreaks
like dengue virus
expanding geographic range
eotaxin ), cxcl10
elevated alanine aminotransferase
continued genomic surveillance
2024 oropouche virus
orov symptoms overlap
expanded clinical studies
pcr positive samples
urine samples
serum samples
samples collected
xlink ">
using serum
time pcr
term consequences
study aimed
severe headache
rash compared
phase ccl11
orov infection
orov diagnosis
improving diagnosis
immunological profiles
high incidence
fold increase
endemic regions
denv underscores
denv infection
denv cases
day 28
cytokine profiles
considered orov
compare clinical
clinical manifestations
better understand
assess long
also observed
5 increased
45 %.
28 days
2024 outbreak